Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Lacidipine
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Lacidipine 4mg tablets
0206020K0AAABAB
|
Lacidipine | Lacidipine | Cardiovascular System | 75,913 |
|
Lacidipine 2mg tablets
0206020K0AAAAAA
|
Lacidipine | Lacidipine | Cardiovascular System | 66,055 |
|
Motens 4mg tablets
0206020K0BBABAB
|
Motens | Lacidipine | Cardiovascular System | 1,263 |
|
Motens 2mg tablets
0206020K0BBAAAA
|
Motens | Lacidipine | Cardiovascular System | 1,137 |
|
Lacidipine 6mg tablets
0206020K0AAAEAE
|
Lacidipine | Lacidipine | Cardiovascular System | 1,048 |
|
Molap 4mg tablets
0206020K0BDAAAB
|
Molap | Lacidipine | Cardiovascular System | 1 |
|
Lacidipine 2mg/5ml oral suspension
0206020K0AAADAD
|
Lacidipine | Lacidipine | Cardiovascular System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.